EVALUATION OF QUALITY OF LIFE OF PATIENTS WITH MALIGNANCY DURING THE COVID-19 PANDEMIC

RS ASGHAR; U JAVAID; MAA BAIG; F RAFIQUE; K FATIMA; MB AFZAL

doi:10.54112/bcsrj.v2022i1.161

Authors

RS ASGHAR Punjab Human Organ Transplantation Authority, Lahore-Pakistan
U JAVAID Punjab Human Organ Transplantation Authority, Lahore-Pakistan
MAA BAIG Department of Public Health, University of Punjab, Lahore-Pakistan
F RAFIQUE Department of Public Health, University of Punjab, Lahore-Pakistan
K FATIMA Department of Public Health, University of Punjab, Lahore-Pakistan
MB AFZAL Department of Public Health, University of Punjab, Lahore-Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2022i1.161

Keywords:

Oncology, Covid-19, cancer patients, quality of life

Abstract

The study's objective was to evaluate patients' quality of life with malignancy during the Covid-19 pandemic. This study was conducted at the Department of Oncology, Anmol Hospital, Lahore, from August 2020- February 2021. 250 stage III and IV cancer patients undergoing chemotherapy were selected for the study. The patients were asked to complete a questionnaire regarding the ongoing covid-19 pandemic, their cognitive responses to it, their preventive measures, and access to medical treatment. In addition, patients were also asked to respond to the European Organization for Research and Treatment of Cancer quality of life. The data analysis showed a significantly low quality of life for pandemic cancer patients (42.6) compared to non-pandemic patients (61.5). The physical (69.1 vs. 71.2) and emotional functioning (69.5 vs. 71.5) did not vary significantly in both groups; however, the cognitive (70.8 vs. 83.2) and social functioning (68.3 vs. 75.1) were significantly high in the reference group (p<0.001). The pandemic did not have much effect on the role functioning of cancer patients. The symptom scale showed a higher value in pandemic patients than the non-pandemic patients, with insomnia (41.0), fatigue (42.7), and appetite loss (27.4) being the most common symptoms. Thus, it can be concluded that the quality of life of cancer patients is seriously affected by covid-19. Thus, necessary measures should be taken to improve such circumstances.

Downloads

Download data is not yet available.

References

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., and de Haes, J. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: Journal of the National Cancer Institute85, 365-376.

Baffert, K.-A., Darbas, T., Lebrun-Ly, V., Pestre-Munier, J., Peyramaure, C., Descours, C., Mondoly, M., Latrouite, S., Bignon, E., and Nicouleau, S. (2021). Quality of life of patients with cancer during the COVID-19 pandemic. in vivo35, 663-670.

Bargon, C., Batenburg, M., Van Stam, L., van der Molen, D. M., Van Dam, I., van der Leij, F., Baas, I., Ernst, M., Maarse, W., and Vermulst, N. (2020). The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients–a prospective, multi-center cohort study. European Journal of Cancer138, S17.

Chen, P., Mao, L., Nassis, G. P., Harmer, P., Ainsworth, B. E., and Li, F. (2020). Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. Journal of sport and health science9, 103.

Gallo, O., Bruno, C., Locatello, L. G., Martelli, F., Cilona, M., Orlando, P., Fancello, G., Maggiore, G., Viberti, F., and Ciabatti, P. (2021). The impact of the COVID-19 pandemic on the quality of life of head and neck cancer survivors. Supportive Care in Cancer29, 6297-6304.

Kutikov, A., Weinberg, D. S., Edelman, M. J., Horwitz, E. M., Uzzo, R. G., and Fisher, R. I. (2020). A war on two fronts: cancer care in the time of COVID-19. Vol. 172, pp. 756-758. American College of Physicians.

Lemon, J., Edelman, S., and Kidman, A. D. (2003). Perceptions of the "Mind-Cancer" relationship among the public, cancer patients, and oncologists. Journal of Psychosocial Oncology21, 43-58.

Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., and Liang, H. (2020). Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The lancet oncology21, 335-337.

Qian, Y., Wu, K., Xu, H., Bao, D., Ran, F., Wei, W., Cheng, T., Huang, D., Lin, X., and Bruera, E. (2020). A survey on physical and mental distress among cancer patients during the COVID-19 epidemic in Wuhan, China. Journal of palliative medicine23, 888-889.

Saini, K. S., de Las Heras, B., de Castro, J., Venkitaraman, R., Poelman, M., Srinivasan, G., Saini, M. L., Verma, S., Leone, M., and Aftimos, P. (2020). Effect of the COVID-19 pandemic on cancer treatment and research. The Lancet Haematology7, e432-e435.

Scott, N. W., Fayers, P., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., Gundy, C., Koller, M., Petersen, M. A., and Sprangers, M. A. (2008). EORTC QLQ-C30 reference values manual.

Wang, H., and Zhang, L. (2020). Risk of COVID-19 for patients with cancer. The Lancet Oncology21, e181.

Younger, E., Smrke, A., Lidington, E., Farag, S., Ingley, K., Chopra, N., Maleddu, A., Augustin, Y., Merry, E., and Wilson, R. (2020). Health-related quality of life and experiences of sarcoma patients during the COVID-19 pandemic. Cancers12, 2288.

Yusuf, A. (2020). Cancer care in the time of COVID-19—a perspective from Pakistan. ecancermedicalscience14.